[ACRS] QoQ Quarter Result on 30-Sep-2017 [#Q3]

Stock
[ACRS] Aclaris Therapeutics, Inc.
Announcement Date
07-Nov-2017
Financial Year
2017
Quarter
30-Sep-2017 [#Q3]
Profit Trend
QoQ- -22.60%
YoY- -70.11%
Quarter Report
ACRS's Result
ACRS's Financial Summary
View:
Show?
Quarter Result
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
Revenue 3,676 1,118 999 684 0 0 0 -
PBT -31,218 -30,229 -24,764 -18,192 -14,838 -12,559 -11,475 95.23%
Tax 1,500 0 -1,830 0 0 0 -40 -
NP -31,218 -30,229 -22,934 -18,192 -14,838 -12,559 -11,475 95.23%
Tax Rate - - - - - - - -
Total Cost 34,894 31,347 23,933 18,876 14,838 12,559 11,475 110.32%
Ratio Analysis
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
NP Margin -849.24 -2,703.85 -2,295.70 -2,659.65 0.00 0.00 0.00 -
Per Share
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
EPS -1.01 -0.98 -0.74 -0.63 -0.56 -0.48 -0.49 62.17%
EPS Diluted -1.01 -0.98 -0.74 -0.63 -0.56 -0.48 -0.49 62.17%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.